You just read:

Impax Receives European Commission Marketing Authorization for NUMIENT™ (Levodopa and Carbidopa) Modified-Release Capsules for the Symptomatic Treatment of Adult Patients with Parkinson's Disease

News provided by

Impax Laboratories, Inc.

Nov 25, 2015, 07:30 ET